Marker Common Stock Shares Outstanding vs Non Current Liabilities Total Analysis

MRKR Stock  USD 1.72  0.02  1.18%   
Marker Therapeutics financial indicator trend analysis is infinitely more than just investigating Marker Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Marker Therapeutics is a good investment. Please check the relationship between Marker Therapeutics Common Stock Shares Outstanding and its Non Current Liabilities Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
To learn how to invest in Marker Stock, please use our How to Invest in Marker Therapeutics guide.

Common Stock Shares Outstanding vs Non Current Liabilities Total

Common Stock Shares Outstanding vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Marker Therapeutics Common Stock Shares Outstanding account and Non Current Liabilities Total. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Marker Therapeutics' Common Stock Shares Outstanding and Non Current Liabilities Total is 0.16. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Marker Therapeutics, assuming nothing else is changed. The correlation between historical values of Marker Therapeutics' Common Stock Shares Outstanding and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Marker Therapeutics are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Common Stock Shares Outstanding i.e., Marker Therapeutics' Common Stock Shares Outstanding and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

0.16
Relationship DirectionPositive 
Relationship StrengthInsignificant

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Non Current Liabilities Total

Most indicators from Marker Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Marker Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
To learn how to invest in Marker Stock, please use our How to Invest in Marker Therapeutics guide.At this time, Marker Therapeutics' Tax Provision is relatively stable compared to the past year. As of 02/18/2025, Enterprise Value is likely to grow to about 27.1 M, while Selling General Administrative is likely to drop slightly above 5.6 M.
 2022 2024 2025 (projected)
Reconciled Depreciation3.7M4.2M2.3M
Interest Income248.1K402.5K291.5K

Marker Therapeutics fundamental ratios Correlations

0.48-0.040.070.920.46-0.81-0.710.690.920.650.920.17-0.040.450.55-0.440.740.670.360.480.95-0.130.06-0.170.32
0.48-0.040.120.370.97-0.06-0.750.650.220.710.220.620.190.810.64-0.290.810.750.450.970.270.27-0.01-0.730.82
-0.04-0.040.94-0.35-0.020.070.030.08-0.070.05-0.07-0.040.23-0.080.04-0.17-0.01-0.070.76-0.02-0.07-0.120.240.08-0.03
0.070.120.94-0.280.070.08-0.020.31-0.020.23-0.02-0.020.44-0.030.29-0.210.16-0.040.890.09-0.010.150.480.090.04
0.920.37-0.35-0.280.39-0.88-0.690.490.930.420.930.16-0.190.470.3-0.370.590.69-0.020.40.94-0.21-0.13-0.170.31
0.460.97-0.020.070.39-0.09-0.830.520.220.630.220.720.020.910.47-0.320.80.840.371.00.280.07-0.23-0.790.92
-0.81-0.060.070.08-0.88-0.090.52-0.32-0.97-0.09-0.970.10.12-0.27-0.010.38-0.3-0.530.02-0.11-0.950.290.02-0.09-0.09
-0.71-0.750.03-0.02-0.69-0.830.52-0.42-0.6-0.51-0.6-0.680.06-0.91-0.30.58-0.77-0.98-0.25-0.82-0.640.170.310.69-0.8
0.690.650.080.310.490.52-0.32-0.420.490.760.49-0.040.210.310.82-0.240.740.380.620.570.510.310.43-0.030.33
0.920.22-0.07-0.020.930.22-0.97-0.60.490.311.0-0.03-0.060.320.23-0.410.470.580.130.241.0-0.210.050.020.16
0.650.710.050.230.420.63-0.09-0.510.760.310.310.40.020.380.93-0.250.860.420.650.650.360.110.12-0.360.39
0.920.22-0.07-0.020.930.22-0.97-0.60.491.00.31-0.03-0.060.320.23-0.410.470.580.130.241.0-0.210.050.020.16
0.170.62-0.04-0.020.160.720.1-0.68-0.04-0.030.4-0.030.020.740.2-0.290.480.670.150.690.03-0.04-0.43-0.880.74
-0.040.190.230.44-0.190.020.120.060.21-0.060.02-0.060.02-0.020.28-0.040.01-0.070.350.02-0.060.870.83-0.020.02
0.450.81-0.08-0.030.470.91-0.27-0.910.310.320.380.320.74-0.020.16-0.370.720.940.160.90.37-0.04-0.36-0.750.96
0.550.640.040.290.30.47-0.01-0.30.820.230.930.230.20.280.16-0.170.70.210.670.50.280.380.43-0.210.19
-0.44-0.29-0.17-0.21-0.37-0.320.380.58-0.24-0.41-0.25-0.41-0.29-0.04-0.37-0.17-0.35-0.53-0.28-0.32-0.430.110.040.26-0.28
0.740.81-0.010.160.590.8-0.3-0.770.740.470.860.470.480.010.720.7-0.350.720.530.820.530.06-0.01-0.430.68
0.670.75-0.07-0.040.690.84-0.53-0.980.380.580.420.580.67-0.070.940.21-0.530.720.170.830.62-0.16-0.34-0.690.84
0.360.450.760.89-0.020.370.02-0.250.620.130.650.130.150.350.160.67-0.280.530.170.390.160.170.43-0.110.21
0.480.97-0.020.090.41.0-0.11-0.820.570.240.650.240.690.020.90.5-0.320.820.830.390.30.08-0.2-0.760.91
0.950.27-0.07-0.010.940.28-0.95-0.640.511.00.361.00.03-0.060.370.28-0.430.530.620.160.3-0.20.04-0.030.21
-0.130.27-0.120.15-0.210.070.290.170.31-0.210.11-0.21-0.040.87-0.040.380.110.06-0.160.170.08-0.20.790.030.05
0.06-0.010.240.48-0.13-0.230.020.310.430.050.120.05-0.430.83-0.360.430.04-0.01-0.340.43-0.20.040.790.41-0.32
-0.17-0.730.080.09-0.17-0.79-0.090.69-0.030.02-0.360.02-0.88-0.02-0.75-0.210.26-0.43-0.69-0.11-0.76-0.030.030.41-0.7
0.320.82-0.030.040.310.92-0.09-0.80.330.160.390.160.740.020.960.19-0.280.680.840.210.910.210.05-0.32-0.7
Click cells to compare fundamentals

Marker Therapeutics Account Relationship Matchups

Marker Therapeutics fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets45.6M68.1M34.4M17.1M19.7M13.6M
Other Current Liab2.7M5.4M3.6M1.9M2.2M2.5M
Total Current Liabilities6.4M12.9M7.8M3.1M3.5M4.6M
Total Stockholder Equity27.3M44.0M19.6M14.1M16.2M17.0M
Property Plant And Equipment Net873.2K21.2M22.2M17.8M20.5M21.5M
Net Debt(9.1M)(30.5M)(4.2M)(15.1M)(13.6M)(12.9M)
Retained Earnings(356.2M)(398.1M)(428.0M)(436.3M)(392.7M)(373.0M)
Accounts Payable2.9M5.1M1.1M961K1.1M1.3M
Cash21.4M42.4M11.8M15.1M17.4M9.6M
Cash And Short Term Investments21.4M42.4M11.8M15.1M17.4M9.6M
Net Receivables1.0M237.02.4M1.0M1.2M1.2M
Common Stock Shares Outstanding4.7M7.7M8.4M8.8M10.1M10.6M
Liabilities And Stockholders Equity45.6M68.1M34.4M17.1M19.7M13.6M
Non Current Liabilities Total1.6M280.2K11.9M11.2M7.0M0.0
Other Current Assets2.1M3.6M2.4M988.1K1.1M1.2M
Other Stockholder Equity383.5M442.0M447.6M450.3M517.9M543.8M
Total Liab18.3M24.1M14.8M3.1M3.5M6.0M
Property Plant And Equipment Gross873.2K21.2M24.9M17.8M20.5M21.5M
Total Current Assets24.4M46.0M16.6M17.1M19.7M10.3M
Short Term Debt204.1K777.6K1.2M577.2K663.8K714.4K
Common Stock50.7K83.1K8.4K8.9K10.2K9.7K
Non Currrent Assets Other(472.0)(21.2M)2.2M(17.8M)(16.0M)(15.2M)
Net Tangible Assets59.3M44.1M27.3M44.0M50.6M53.1M
Net Invested Capital27.3M44.0M19.6M14.1M12.6M24.2M
Net Working Capital18.0M33.1M8.8M14.1M12.6M20.6M
Capital Stock50.7K83.1K8.4K8.9K8.0K7.6K

Additional Tools for Marker Stock Analysis

When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.